Literatura académica sobre el tema "Yifeng tang"

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Yifeng tang".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Yifeng tang"

1

Han, Wu, Jie Liu, Yifan Luo, and Hongqu Tang. "No longer endemic to Africa: Kribiodosis Kieffer, 1921 (Diptera, Chironomidae) new to Oriental China with a phylogeny and expanded adult generic diagnoses." Zootaxa 5072, no. 6 (2021): 560–74. https://doi.org/10.11646/zootaxa.5072.6.4.

Texto completo
Resumen
Han, Wu, Liu, Jie, Luo, Yifan, Tang, Hongqu (2021): No longer endemic to Africa: Kribiodosis Kieffer, 1921 (Diptera, Chironomidae) new to Oriental China with a phylogeny and expanded adult generic diagnoses. Zootaxa 5072 (6): 560-574, DOI: 10.11646/zootaxa.5072.6.4
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Hamer, Matthew T., André Ibáñez Weemaels, Yifan Fu, et al. "New insights into the diversity and distribution of Leptanillinae (Formicidae) within China." Zootaxa 5471, no. 1 (2024): 99–112. https://doi.org/10.11646/zootaxa.5471.1.6.

Texto completo
Resumen
Hamer, Matthew T., Weemaels, André Ibáñez, Fu, Yifan, Xuan, Liu, Tse, Cheung Yau Leo, Tang, Kit Lam, Guénard, Benoit (2024): New insights into the diversity and distribution of Leptanillinae (Formicidae) within China. Zootaxa 5471 (1): 99-112, DOI: 10.11646/zootaxa.5471.1.6, URL: http://dx.doi.org/10.11646/zootaxa.5471.1.6
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Dong1, Yang, Shengchang Duan1, Qiuju Xia, et al. "Dual domestications and origin of traits in grapevine evolution." Science 379 (March 3, 2023): 892–901. https://doi.org/10.1126/science.add8655.

Texto completo
Resumen
Dong1, Yang, Duan1, Shengchang, Xia, Qiuju, Liang, Zhenchang, Dong1, Xiao, Margaryan, Kristine, Musayev, Mirza, Goryslavets, Svitlana, Zduni, Goran, Bert, Pierre-François, Lacombe11, Thierry, Maul1, Erika, Nick, Peter, Bitskinashvili, Kakha, Bisztray, György Dénes, Drori, Elyashiv, Lorenzis, Gabriella De, Cunha, Jorge, Popescu, Carmen Florentina, Arroyo-Garcia, Rosa, Arnold, Claire, Ergül, Ali, Zhu1, Yifan, Ma, Chao, Wang, Shufen, Liu1, Siqi, Tang, Liu, Wang, Chunping, Li, Dawei, Pan, Yunbing (2023): Dual domestications and origin of traits in grapevine evolution. Science 379: 892-901, DOI: 10
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Cortes-Cros, Marta, Henrik Moebitz, Stephanie Barbe, et al. "Abstract PR007: Discovery of HRO761, a novel, first-in-class clinical stage WRN inhibitor with potent and selective anti-tumor activity in cancers with microsatellite instability." Molecular Cancer Therapeutics 22, no. 12_Supplement (2023): PR007. http://dx.doi.org/10.1158/1535-7163.targ-23-pr007.

Texto completo
Resumen
Abstract The RecQ DNA helicase WRN was identified as a synthetic lethal target in tumors with microsatellite instability (MSI) by several genetic screens. Despite recent advances in the treatment of MSI tumors by immune checkpoint inhibitors, a significant proportion of patients still fails to respond to or relapses after single agent anti-PD1 or combination of anti-PD1 plus anti-CTLA4 treatments. We present the biochemical, cellular and pharmacological characterization of the first potent and selective WRN helicase inhibitor, HRO761. We show that HRO761 is an allosteric WRN inhibitor that bin
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Zhou, Yifan, Yusra B. Medik, Bhakti Patel, et al. "Abstract 5545: Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration." Cancer Research 82, no. 12_Supplement (2022): 5545. http://dx.doi.org/10.1158/1538-7445.am2022-5545.

Texto completo
Resumen
Abstract Immunotherapies such as anti-CTLA-4 immune checkpoint blockade (ICB) have revolutionized cancer treatment, yet quality of life and continuation of therapy can be constrained by off-target tissue damage or immune-related adverse events (irAEs). At present, there is limited understanding of irAE mechanisms, hampering development of approaches to mitigate their damage. We addressed this problem by generating animal models of intestinal irAE. Our results show that disruption of homeostatic immunity by genetic predisposition to intestinal inflammation or acute gastrointestinal infection se
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Yang, Cuiqing, Yifang Wang, Tingting Liu, et al. "Abstract 2899: Small molecule inhibitor of ubiquitin ligase CBL-B enhanced anti-tumor response of CAR-T and CAR-NK cell therapies." Cancer Research 83, no. 7_Supplement (2023): 2899. http://dx.doi.org/10.1158/1538-7445.am2023-2899.

Texto completo
Resumen
Abstract Introduction: Chimeric antigen receptor (CAR) T-cell therapy is an emerging therapeutic option for cancer treatment. However, its efficacy is limited, especially in solid tumors. This is partly because the CAR T cells become dysfunctional and exhausted in the tumor microenvironment. However, the key pathways responsible for impaired function of exhausted T cells remain unclear. Immunosuppressive cytokines or checkpoint proteins like TGF-β and PD-L1, are overproduced, which may lead to the downregulation of CD8+ T cell action and the promotion of T-reg maturation. E3 ligase Casitas B-L
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Wang, Xiaobin Summer, Sining Zhu, Haili Ding, et al. "Abstract 360: Discovery of selective and orally bioavailable PKMYT1 inhibitor: characterization of anti-tumor activities as single and dual agents." Cancer Research 85, no. 8_Supplement_1 (2025): 360. https://doi.org/10.1158/1538-7445.am2025-360.

Texto completo
Resumen
Abstract Advancing effective cancer therapies requires innovative approaches to better understand complex biological interactions. PKMYT1, a crucial regulator of the cell cycle involved in the G2/M transition through inhibitory phosphorylation of CDK1, has emerged as a promising therapeutic target. Inactivation of PKMYT1 is synthetically lethal in tumor cells with genomic alterations leading to high replication stress, such as CCNE1 amplification, which is frequently found in high-grade serous ovarian, uterine, and gastro-esophageal cancers. In this report, we present a series of potent PKMYT1
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Yang, Cuiqing, Fuwei Jiang, Yifang Wang, et al. "Abstract 2900: To develop a next generation NK therapy with deep and durable response by engineered CD16 enhancing NK cytotoxicity." Cancer Research 83, no. 7_Supplement (2023): 2900. http://dx.doi.org/10.1158/1538-7445.am2023-2900.

Texto completo
Resumen
Abstract Introduction: Allogeneic NK cell-based therapies have been demonstrated to elicit clinical efficacy against hematopoietic malignancies. Unlike T-cell therapies, allogeneic NK cells do not cause toxicities such as serious cytokine release syndrome, neurotoxicity, or graft-vs-host-disease, and are less expensive. We believe NK cell-based therapies provide an important platform for “off-shelf” allogeneic cell therapies, so we designed a panel of arming strategies to enhance NK cytotoxicity and elicit deep and durable response. CD16a is a transmembrane protein that co-localizes with CD3ζ
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Yang, Cuiqing, Fuwei Jiang, Yifang Wang, et al. "Abstract 4087: Co-expression of membrane bound IL-15 enhanced anti-tumor response of CAR-T." Cancer Research 83, no. 7_Supplement (2023): 4087. http://dx.doi.org/10.1158/1538-7445.am2023-4087.

Texto completo
Resumen
Abstract Introduction: Chimeric antigen receptors (CARs) T cells have been used successfully to treat patients with hematologic malignancies, but showed less effective in solid tumors. We investigated multiple approaches to engineer and enhance CAR-T activity in solid tumors. It has been previously reported that improvement in the quality of CAR-T cells, through CAR design or manufacturing optimization, could enhance the therapeutic potential of CAR-T cells. One parameter influencing the effectiveness of CAR-T cell therapy is the differentiation status of the final product: CAR-T cells that ar
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Yang, Cuiqing, Yifang Wang, Tingting Liu, et al. "Abstract 4078: Optimized chimeric antigen receptors (CARs) for CAR-NK cell therapies." Cancer Research 83, no. 7_Supplement (2023): 4078. http://dx.doi.org/10.1158/1538-7445.am2023-4078.

Texto completo
Resumen
Abstract Introduction: CAR-T-cell therapy has shown great success in treating hematopoietic malignancies. Allogenic NK cell-based therapies have also been shown to mount potent responses against hematopoietic malignancies. Unlike T-cell therapies, allogeneic NK cells do not cause toxicities such as serious cytokine release syndrome, neurotoxicity, or graft-vs-host-disease. Several groups have demonstrated the clinical efficacy of allogeneic CAR-expressing NK cells that utilize CARs developed for T-cells. However, activating receptor signaling in NK cells is different from T cells. NK cell-medi
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Yifeng tang"

1

Ming, Huang, та Yang Tongfu, ред. 藝風藏書記. Shanghai gu ji chu ban she, 2007.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Yifeng tang wen ji. Zhao hua chu ban she, 2017.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Yifeng tang shi cun: [4 juan] ; Bi xiang ci : [1 juan]. Beijing shi Zhongguo shu dian, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Capítulos de libros sobre el tema "Yifeng tang"

1

Tan, Jiarui, Yifan Li, and Holger Briel. "Growing Up a Pirate." In The Piracy Years. Liverpool University Press, 2023. http://dx.doi.org/10.3828/liverpool/9781802070545.003.0009.

Texto completo
Resumen
This chapter contains testimonials by Jiarui Tan and Yifan Li, both of whom display a passion for their preferred medium: music and video gaming respectively. Their narratives give a detailed account of different kinds of structures informing and sharing media discourses and speak of their inventiveness in overcoming such strictures. It explores how much the emerging online community of gamers and music fans has succeeded in creating new collaborations, growing up and enlarging horizons together. The chapter illustrates the liberating, emancipatory, and lasting power of media piracy and the wa
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!